These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17196590)

  • 1. Pharmacological activation of mGlu2/3 metabotropic glutamate receptors protects retinal neurons against anoxic damage in the goldfish Carassius auratus.
    Beraudi A; Bruno V; Battaglia G; Biagioni F; Rampello L; Nicoletti F; Poli A
    Exp Eye Res; 2007 Mar; 84(3):544-52. PubMed ID: 17196590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group II metabotropic glutamate receptors regulate the vulnerability to hypoxic brain damage.
    Poli A; Beraudi A; Villani L; Storto M; Battaglia G; Di Giorgi Gerevini V; Cappuccio I; Caricasole A; D'Onofrio M; Nicoletti F
    J Neurosci; 2003 Jul; 23(14):6023-9. PubMed ID: 12853420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.
    Molinaro G; Traficante A; Riozzi B; Di Menna L; Curto M; Pallottino S; Nicoletti F; Bruno V; Battaglia G
    Mol Pharmacol; 2009 Aug; 76(2):379-87. PubMed ID: 19439499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy.
    Ngomba RT; Biagioni F; Casciato S; Willems-van Bree E; Battaglia G; Bruno V; Nicoletti F; van Luijtelaar EL
    Neuropharmacology; 2005; 49 Suppl 1():89-103. PubMed ID: 16043198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.
    Di Liberto V; Bonomo A; Frinchi M; Belluardo N; Mudò G
    Neuroscience; 2010 Feb; 165(3):863-73. PubMed ID: 19909793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells.
    D'Onofrio M; Arcella A; Bruno V; Ngomba RT; Battaglia G; Lombari V; Ragona G; Calogero A; Nicoletti F
    J Neurochem; 2003 Mar; 84(6):1288-95. PubMed ID: 12614329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
    Marek GJ; Wright RA; Schoepp DD; Monn JA; Aghajanian GK
    J Pharmacol Exp Ther; 2000 Jan; 292(1):76-87. PubMed ID: 10604933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands.
    Matrisciano F; Scaccianoce S; Del Bianco P; Panaccione I; Canudas AM; Battaglia G; Riozzi B; Ngomba RT; Molinaro G; Tatarelli R; Melchiorri D; Nicoletti F
    J Neurochem; 2005 Jun; 93(5):1345-52. PubMed ID: 15934953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.
    Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F
    Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of liver X receptor protects inner retinal damage induced by N-methyl-D-aspartate.
    Zheng S; Yang H; Chen Z; Zheng C; Lei C; Lei B
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1168-80. PubMed ID: 25613943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF attenuates retinal cell death caused by chemically induced hypoxia in rats.
    Ikeda K; Tanihara H; Honda Y; Tatsuno T; Noguchi H; Nakayama C
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2130-40. PubMed ID: 10440270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
    Lorrain DS; Schaffhauser H; Campbell UC; Baccei CS; Correa LD; Rowe B; Rodriguez DE; Anderson JJ; Varney MA; Pinkerton AB; Vernier JM; Bristow LJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1622-32. PubMed ID: 12825094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreous injection of a membrane depolarization agent causes retinal degeneration via matrix metalloproteinase-9.
    Mali RS; Cheng M; Chintala SK
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2125-32. PubMed ID: 15914633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.
    Arcella A; Carpinelli G; Battaglia G; D'Onofrio M; Santoro F; Ngomba RT; Bruno V; Casolini P; Giangaspero F; Nicoletti F
    Neuro Oncol; 2005 Jul; 7(3):236-45. PubMed ID: 16053698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats.
    Hikichi H; Kaku A; Karasawa J; Chaki S
    J Pharmacol Sci; 2013; 122(1):10-6. PubMed ID: 23603933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of c-Fos induction in the brain by the mGlu2/3 receptor antagonist LY341495 and agonist LY354740: evidence for widespread endogenous tone at brain mGlu2/3 receptors in vivo.
    Linden AM; Bergeron M; Schoepp DD
    Neuropharmacology; 2005; 49 Suppl 1():120-34. PubMed ID: 16023151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
    Galici R; Echemendia NG; Rodriguez AL; Conn PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
    Koike H; Iijima M; Chaki S
    Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.